PIK3CA and cancer: In addition to experiments in genetically engineered mice [31,32], the first generation of PI3Kα-specific inhibitors, while less isoform selective than the more recent compounds, have been instrumental in defining the biologic role of different PI3K isoforms in normal and cancer cells [33,38,39].